NFL BIOSCIENCES |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.435 EUR | +3.62% |
|
+5.41% | +69.10% |
| 05-29 | NFL Biosciences: study with CEA presented at congress | CF |
| 05-21 | NFL Biosciences receives positive feedback from the FDA | CF |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NFL BIOSCIENCES | Bio Therapeutic Drugs | +3.62% | +5.41% | +69.10% | -21.20% | - | 24.73M |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- ALNFL Stock
- Charts NFL Biosciences
- Comparison Chart
